AstraZeneca Plc

0:24:07

Bloomberg Turnaround: AstraZeneca

0:00:20

The UK's $174B Company, AstraZeneca

0:03:31

Transforming Global Healthcare: The Role of Biopharmaceuticals Medical at AstraZeneca

0:02:00

Procurement at AstraZeneca in Lisbon

0:05:31

Postdocs in Industry at AstraZeneca

0:00:42

AstraZeneca’s Immunotherapy Imjudo (tremelimumab) Wins FDA Approval for Liver Cancer

0:00:41

Study reveals AstraZeneca and Pfizer vaccines linked to rare neurological side effects

0:10:06

AstraZeneca to Start Covid-19 Testing This Week

0:05:16

Unlocking scientific discovery with collaboration

0:04:24

AstraZeneca Postdoc Case Study: Data Science

0:01:03

Why 0.1% of our DNA Matters: Shaping the Future of Medicine

0:01:00

AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time

0:03:24

AstraZeneca Faces Mounting Vaccine Questions After Dosing Error

0:02:06

ASTRAZENECA PLC STOCK ($AZN): HONEST REVIEW (Pros & Cons)

1:32:53

$AZN AstraZeneca Q1 2025 Earnings Conference Call

0:02:57

AstraZeneca Lowers Vaccine Efficacy

0:00:59

AstraZeneca CEO Pascal Soriot on breast cancer drug trial

0:35:42

AstraZeneca Plc (AZN) Summary Earnings Call

0:02:22

More Nations Pause Use of AstraZeneca Shot

0:03:56

AstraZeneca Vaccine: Key Facts Around Safety, Risks

0:01:00

Astrazeneca’s Blockbuster Drug Scores Major Win In Bladder Cancer | N18S | CNBC TV18

0:07:27

AstraZeneca CEO Soriot on Pharmaceuticals in China

0:02:20

EU Regulator Backs AstraZeneca Covid Vaccine as It Speeds Safety Review

0:00:18

La EMA declara 'segura y eficaz' la vacuna AstraZeneca